Agile Therapeutics, Inc. (AGRX)
Aug 26, 2024 - AGRX was delisted (reason: acquired by Insud Pharma)
1.510
0.00 (0.00%)
Inactive · Last trade price
on Aug 26, 2024
Agile Therapeutics Employees
Agile Therapeutics had 19 employees as of December 31, 2023. The number of employees decreased by 3 or -13.64% compared to the previous year.
Employees
19
Change (1Y)
-3
Growth (1Y)
-13.64%
Revenue / Employee
$1,135,211
Profits / Employee
-$834,632
Market Cap
10.43M
Employees Chart
AGRX News
- 3 months ago - Agile Therapeutics Inc. Announces Completion of Acquisition by Insud Pharma, S.L. - GlobeNewsWire
- 4 months ago - Agile Leadership for Pharma and Biopharma Professionals in a Hybrid World: 2-Day Training Course (Online) November 18-19, 2024 - Become Competent and Familiar in a Range of Well-Recognised Leadership Techniques - GlobeNewsWire
- 5 months ago - AGILE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Agile Therapeutics, Inc. - AGRX - Business Wire
- 5 months ago - Agile Therapeutics Inc. Announces Definitive Merger Agreement with Insud Pharma, S.L. - GlobeNewsWire
- 7 months ago - Agile Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 8 months ago - Agile Therapeutics, Inc. (AGRX) Q4 2023 Earnings Call Transcript - Seeking Alpha
- 8 months ago - Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate Update - GlobeNewsWire
- 9 months ago - Agile Therapeutics Announces Delisting from Nasdaq - GlobeNewsWire